A Shot at Dendritic Cell-Based Vaccine Strategy against HIV-1

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Larijani Mona Sadat; SADAT SEYED MEHDI; BOLHASSANI AZAM; RAMEZANI AMITIS

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASES Year:2019 | Volume:7 | Issue:4 Page(s): 89-92

Download Full-Text

View:

176

Download:

Cites:

Information Journal Paper

Title

A Shot at Dendritic Cell-Based Vaccine Strategy against HIV-1

Author(s)

Larijani Mona Sadat | SADAT SEYED MEHDI | BOLHASSANI AZAM | RAMEZANI AMITIS | Issue Writer Certificate

Keywords

Antiretroviral Therapy

Dendritic Cells

HIV-1

Abstract

Introduction: Despite considerable efforts to control AIDS pandemic, it is still one of the significant infectious concerns worldwide. The advance in medical research has led to the development of highly active Antiretroviral Therapy with a considerable effect to suppress the disease. However, an effective vaccine capable of eradication the HIV pandemic is not available yet. Failure to develop a prophylactic vaccine diverted the efforts to clinical trials of therapeutic vaccines. Methods: Here, we review different approaches to dendritic cell-based HIV therapeutic vaccines. We have summarized the dendritic cell-based trials as HIV therapeutic vaccination, registered in the United States clinical trial database. Results and Conclusion: The strategies applied in the clinical trials were mostly of low success rates; however, by using dendritic cell therapy, they could trigger the host immune response against HIV-1 infections.

Cites

No record.

References

Cite

APA: Copy

Larijani, Mona Sadat, SADAT, SEYED MEHDI, BOLHASSANI, AZAM, & RAMEZANI, AMITIS. (2019). A Shot at Dendritic Cell-Based Vaccine Strategy against HIV-1. JOURNAL OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASES, 7(4), 89-92. SID. https://sid.ir/paper/343228/en

Vancouver: Copy

Larijani Mona Sadat, SADAT SEYED MEHDI, BOLHASSANI AZAM, RAMEZANI AMITIS. A Shot at Dendritic Cell-Based Vaccine Strategy against HIV-1. JOURNAL OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASES[Internet]. 2019;7(4):89-92. Available from: https://sid.ir/paper/343228/en

IEEE: Copy

Mona Sadat Larijani, SEYED MEHDI SADAT, AZAM BOLHASSANI, and AMITIS RAMEZANI, “A Shot at Dendritic Cell-Based Vaccine Strategy against HIV-1,” JOURNAL OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASES, vol. 7, no. 4, pp. 89–92, 2019, [Online]. Available: https://sid.ir/paper/343228/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops